Redefining cancer drivers with tissue-specific context
Cancer Cell · 2026-05 · 44 (5) · 907-909
DOI: 10.1016/j.ccell.2026.03.007 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2026-05. Verfasst von Maria Kalyva und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, …. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 8 Literaturangaben. Gefördert von: UCL Cancer Institute.
Abstract (Originalsprache)
In this issue of Cancer Cell, Bandlamudi and colleagues analyze over 50,000 tumors spanning 64 cancer types, revealing how tissue context dictates the prevalence and evolutionary timing of somatic driver alterations. Their findings underscore the need to move away from a purely gene-centric view of oncology toward a context-aware framework.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
- Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Electronic add…
Förderung
- UCL Cancer Institute
Zitieren
APA
Kalyva, M., & McGranahan, N. (2026). Redefining cancer drivers with tissue-specific context. Cancer Cell, 44(5), 907-909. https://doi.org/10.1016/j.ccell.2026.03.007
Vancouver
Kalyva M, McGranahan N. Redefining cancer drivers with tissue-specific context. Cancer Cell. 2026;44(5):907-909. doi:10.1016/j.ccell.2026.03.007
BibTeX
@article{Kalyva2026,
author = {Kalyva, Maria and McGranahan, Nicholas},
title = {Redefining cancer drivers with tissue-specific context},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {5},
pages = {907--909},
doi = {10.1016/j.ccell.2026.03.007}
}
EUVIMED